🟢 Veradermics is trading 4.03% up in pre-market with no company-specific catalyst identified

Veradermics is trading at $139.00, up 4.03% in pre-market, alongside a broader U.S. futures rebound.

• Futures recovered after initially falling as investors assessed the midterm results; major indexes were positive in the supplied market context.
• No clear company-specific announcement for November 4 surfaced, and no source directly linked the rebound to Veradermics.
• The company’s latest listed release is dated October 19.